National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1211031

History of Changes from the VAERS Wayback Machine

First Appeared on 6/25/2021

VAERS ID: 1211031
VAERS Form:2
Age:
Sex:Male
Location:Foreign
Vaccinated:2021-03-10
Onset:2021-03-24
Submitted:0000-00-00
Entered:2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 1 - / OT

Administered by: Other      Purchased by: ??
Symptoms: Sudden death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-03-24
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ATORVASTATIN; BISOPROLOL; CLOPIDOGREL; KAYEXALATE; LEVOTHYROXINE; OROCAL [CALCIUM CARBONATE]; PANTOPRAZOLE; PARACETAMOL; RENVELA; SPECIAFOLDINE; TRINITRIN; UN ALFA; WARFARIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic hemodialysis; Chronic kidney disease stage 5 (with hemodialysis); Coronary bypass (triple coronary bypass grafting); Ischaemic heart disease ((triple coronary bypass grafting with complications)); Peripheral arterial occlusive disease (multi-stented PAD); Valvular heart disease NOS ((calcified aortic stenosis tight))
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': FRPFIZER INC2021380261

Write-up: sudden death; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-NT20210907. A 65-year-old male patient received first dose of bnt162b2 (COMIRNATY, solution for injection, lot: EP2166), intramuscular on 10Mar2021 as single dose for covid-19 immunisation. Medical history included chronic kidney disease stage V (with hemodialysis), chronic hemodialysis, peripheral arterial occlusive disease (multi-stented PAD), ischaemic heart disease (triple coronary bypass grafting with complications) and valvular heart disease (calcified aortic stenosis tight). Concomitant medications included atorvastatin; bisoprolol; clopidogrel; sodium polystyrene sulfonate (KAYEXALATE); levothyroxine; calcium carbonate (OROCAL); pantoprazole; paracetamol; sevelamer carbonate (RENVELA); folic acid (SPECIAFOLDINE); glyceryl trinitrate (TRINITRIN); alfacalcidol (UN ALFA) and warfarin. The patient did not have Sars-CoV2 infection. The physician reported sudden death of the patient in a few minutes while preparing to come to his dialysis session on 24Mar2021. He was 14 days after a first dose of bnt162b2 and had a significant cardiovascular history. The patient died on 24Mar2021. It was unknown if autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: sudden death

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1211031&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166